Read + Share
Santiago JA, Babico M, Stitt G, Thomas CA, et al. Low-dose intrathecal rituximab is a safe and potentially effective treatment for
pediatric neuroimmunologic disorders. J Neuroimmunol 2021;359:577687.
PMID: 34364103
|
 |
|
Santiago JA, Babico M, Stitt G, Thomas CA, et al. Low-dose intrathecal rituximab is a safe and potentially effective treatment for
pediatric neuroimmunologic disorders. J Neuroimmunol 2021;359:577687.
PMID: 34364103
|
|
|
|